The MSD GOLD SULFO-TAG Anti-Human IgG Antibody is a monoclonal antibody that binds human immunoglobulin G (IgG), serving as an effective primary or secondary detection reagent in MSD assays. MSD has implemented stringent quality control measures for MSD GOLD SULFO-TAG Anti-Human IgG Antibody to ensure lot-to-lot reproducibility, meeting the specific requirements of critical assays and longitudinal studies.
The MSD GOLD SULFO-TAG Anti-Human IgG Antibody (Catalog No. D21APR-6) is supplied at a stock concentration of 400 µg/mL.
Key Features
- Meets MSD GOLD products' rigorous specifications for lot-to-lot consistency and precision
- Recognizes all IgG subclasses and has no cross-reactivity with other immunoglobulin isotypes (IgA and IgM)
- Functionally tested to measure IgG antibody against multiple antigens in human samples relevant to COVID-19, Mpox, and respiratory viral disease research applications
- Ideal for vaccine and epidemiology studies, serology, and screening applications
Multi-lot Functional Performance
The functional performance of three independent lots of MSD GOLD SULFO-TAG Anti-Human IgG Antibody was tested on 33 antigens across five V-PLEX Serology panels using a panel of serum samples (N=12-21). Representative data for the SARS-CoV-2 Spike, Mpox A35R, and HCoV-OC43 Spike antigens are shown below (Figures a, b, and c). The graphs demonstrate excellent inter-lot concordance for three MSD GOLD SULFO-TAG Anti-Human IgG Antibody lots in measuring serum IgG levels.
Click image to enlarge
Figure: Functional performance: Inter-lot concordance for three MSD GOLD SULFO-TAG Anti-Human IgG Antibody lots in measuring serum IgG levels against a) SARS-CoV-2 Spike antigen, b) Mpox virus A35R antigen, and c) Human Coronavirus (HCoV) OC43 Spike antigen.
-
-
Specifications
-
-
Documentation
-
References
Analyte(s)
|
|
IgG
|
|
Species
|
|
Human
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
2-8 °C
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Inserts
|
|
|
Certificate of analysis
|
|
|
Title
|
Journal
|
Year
|
|
Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
|
|
|
|
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
|
|
|
|
MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies
|
|
|
|
Clinical Performance of Three Commercial and Two In-House Multiplex Assays for SARS-CoV-2 Antibody Detection in Dried Blood Spot Specimens
|
|
|
|
SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters